a public good project by the
Synthesis
Company
of California

© 2026

Ada Rephaeli | doi.page

0 works0 citations0 h-index

Ada Rephaeli

Rabin Medical Center(IL)

Publications by Year

Research Areas

Histone Deacetylase Inhibitors Research, Cancer therapeutics and mechanisms, Chemotherapy-induced cardiotoxicity and mitigation, Retinoids in leukemia and cellular processes, Cancer Treatment and Pharmacology

Most-Cited Works

→ Doxorubicin-DNA Adducts Induce a Non-Topoisomerase II–Mediated Form of Cell Death(2006)312 cited
→ The Power and Potential of Doxorubicin‐DNA Adducts(2005)166 cited
→ The effect of membrane potential on the mammalian sodium‐potassium pump reconstituted into phospholipid vesicles.(1987)118 cited
→ Novel anticancer prodrugs of butyric acid. 2(1992)90 cited
→ Derivatives of butyric acid as potential anti‐neoplastic agents(1991)90 cited
→ Butyric acid prodrugs are histone deacetylase inhibitors that show antineoplastic activity and radiosensitizing capacity in the treatment of malignant gliomas(2005)82 cited

→ Prodrugs of butyric acid from bench to bedside: Synthetic design, mechanisms of action, and clinical applications(2000)

78 cited

→ The histone deacetylase inhibitor AN-9 has selective toxicity to acute leukemia and drug-resistant primary leukemia and cancer cell lines(2002)71 cited

→ Activation of DNA damage response pathways as a consequence of anthracycline-DNA adduct formation(2012)71 cited

Molecular basis for the synergistic interaction of adriamycin with the formaldehyde-releasing prodrug pivaloyloxymethyl butyrate (AN-9).(2001)